Skip to main content

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

Author
Abstract
:

To test the hypothesis that chronic treatment of early-stage Huntington disease (HD) with high-dose coenzyme Q10 (CoQ) will slow the progressive functional decline of HD.

Year of Publication
:
2017
Journal
:
Neurology
Volume
:
88
Issue
:
2
Number of Pages
:
152-159
Date Published
:
2017
ISSN Number
:
0028-3878
URL
:
http://www.neurology.org/cgi/pmidlookup?view=long&pmid=27913695
DOI
:
10.1212/WNL.0000000000003478
Short Title
:
Neurology
Download citation